Identity of hemolysins produced by Vibrio cholerae non-O1 and V. cholerae O1, biotype El Tor. 1986

K Yamamoto, and Y Ichinose, and N Nakasone, and M Tanabe, and M Nagahama, and J Sakurai, and M Iwanaga

Hemolysins purified from non-O1 Vibrio cholerae (non-O1 hemolysin) and a Vibrio cholerae O1, biotype El Tor (El Tor hemolysin) were investigated for their homology. The hemolysins were isolated from the culture supernatant fluids by ammonium sulfate precipitation and gel filtration on Sephadex G-100 columns. The purified hemolysins gave single bands with an identical mobility on conventional polyacrylamide gel disc electrophoresis. The molecular weights of the non-O1 and El Tor hemolysins were estimated to be about 60,000 by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and the amino acid compositions of the hemolysins were very similar. The specific activities of the hemolysins were identical, and both hemolysins were neutralized to the same extent with antisera against the homologous and heterologous hemolysins. Ouchterlony double immunodiffusion tests with both hemolysins and antihemolysin serum gave a common (fused) precipitin line. These data indicate that the non-O1 hemolysin is biologically, physicochemically, and immunologically indistinguishable from the El Tor hemolysin.

UI MeSH Term Description Entries
D007163 Immunosorbent Techniques Techniques for removal by adsorption and subsequent elution of a specific antibody or antigen using an immunosorbent containing the homologous antigen or antibody. Immunoadsorbent Techniques,Immunoadsorbent Technics,Immunosorbent Technics,Immunoadsorbent Technic,Immunoadsorbent Technique,Immunosorbent Technic,Immunosorbent Technique,Technic, Immunoadsorbent,Technic, Immunosorbent,Technics, Immunoadsorbent,Technics, Immunosorbent,Technique, Immunoadsorbent,Technique, Immunosorbent,Techniques, Immunoadsorbent,Techniques, Immunosorbent
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D005779 Immunodiffusion Technique involving the diffusion of antigen or antibody through a semisolid medium, usually agar or agarose gel, with the result being a precipitin reaction. Gel Diffusion Tests,Diffusion Test, Gel,Diffusion Tests, Gel,Gel Diffusion Test,Immunodiffusions,Test, Gel Diffusion,Tests, Gel Diffusion
D006460 Hemolysin Proteins Proteins from BACTERIA and FUNGI that are soluble enough to be secreted to target ERYTHROCYTES and insert into the membrane to form beta-barrel pores. Biosynthesis may be regulated by HEMOLYSIN FACTORS. Hemolysin,Hemolysins,Hemalysins,Proteins, Hemolysin
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial
D014734 Vibrio cholerae The etiologic agent of CHOLERA. Bacillus cholerae,Bacillus cholerae-asiaticae,Liquidivibrio cholerae,Microspira comma,Pacinia cholerae-asiaticae,Spirillum cholerae,Spirillum cholerae-asiaticae,Vibrio albensis,Vibrio cholera,Vibrio cholerae-asiaticae,Vibrio comma

Related Publications

K Yamamoto, and Y Ichinose, and N Nakasone, and M Tanabe, and M Nagahama, and J Sakurai, and M Iwanaga
March 1994, Lancet (London, England),
K Yamamoto, and Y Ichinose, and N Nakasone, and M Tanabe, and M Nagahama, and J Sakurai, and M Iwanaga
April 2007, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases,
K Yamamoto, and Y Ichinose, and N Nakasone, and M Tanabe, and M Nagahama, and J Sakurai, and M Iwanaga
November 1991, CDR (London, England : Weekly),
K Yamamoto, and Y Ichinose, and N Nakasone, and M Tanabe, and M Nagahama, and J Sakurai, and M Iwanaga
June 1993, Journal of clinical microbiology,
K Yamamoto, and Y Ichinose, and N Nakasone, and M Tanabe, and M Nagahama, and J Sakurai, and M Iwanaga
August 2005, Japanese journal of infectious diseases,
K Yamamoto, and Y Ichinose, and N Nakasone, and M Tanabe, and M Nagahama, and J Sakurai, and M Iwanaga
January 1966, Bulletin of the World Health Organization,
K Yamamoto, and Y Ichinose, and N Nakasone, and M Tanabe, and M Nagahama, and J Sakurai, and M Iwanaga
November 2009, Emerging infectious diseases,
K Yamamoto, and Y Ichinose, and N Nakasone, and M Tanabe, and M Nagahama, and J Sakurai, and M Iwanaga
January 2020, Scientific reports,
K Yamamoto, and Y Ichinose, and N Nakasone, and M Tanabe, and M Nagahama, and J Sakurai, and M Iwanaga
September 1985, Journal of clinical microbiology,
K Yamamoto, and Y Ichinose, and N Nakasone, and M Tanabe, and M Nagahama, and J Sakurai, and M Iwanaga
March 1997, Journal of clinical microbiology,
Copied contents to your clipboard!